Tel Aviv Sourasky Medical Center

Name

Tel Aviv Sourasky Medical Center

Legal name

Tel Aviv Sourasky Medical Center

Website

https://tasmc.org.il

Company type

Private

Founded year

1961

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Academic Medical Center / Hospital Services

NAICS

General Medical and Surgical Hospitals (6221), General Medical and Surgical Hospitals (622110)

SIC

Services-Hospitals (8060), Services-General Medical & Surgical Hospitals, Nec (8062)

akta.pro primary industry

Community & Regional General Hospitals (HLAFAAAB)

akta.pro secondary industries

International/Medical Tourism Hospital Systems (HLAFAAAN), Safety-Net & Public Hospitals (HLAFAAAD), Humanitarian Health & Emergency Medical Relief NGOs (HLAJAKAE), Emergency Medical Care & Field Hospitals (BPADADAC)

Keywords

• Academic medical center
• Healthcare services
• Clinical research
• Medical tourism
• Emergency medicine

Headquarters

HQ city

Tel Aviv

HQ country

Israel

HQ region

Middle East

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales, Others

Revenue model

1. Patient Care Services: Core revenue from providing comprehensive medical services to patients including hospitalizations, outpatient visits, surgeries, emergency care, and diagnostic services. As a public municipal-government hospital, services are provided to all residents with significant government subsidies.
2. Medical Tourism: International patients pay for medical services not covered by Israeli public health insurance. The medical center provides concierge services, language support, and comprehensive treatment coordination.
3. Philanthropy and Donations: Ichilov Association of Friends raises funds for infrastructure upgrades, innovative facilities, and medical initiatives. Donations fund new hospital wings, medical technologies, and groundbreaking medical programs.
4. Clinical Research: Revenue from conducting clinical trials for pharmaceutical and biotechnology companies. The hospital ranks first in clinical research activity in Israel with 2,700 active clinical trials and 200 research collaborations worldwide.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

Core offering

Tel Aviv Sourasky Medical Center (Ichilov) is Israel's second-largest municipal-government academic medical center, operating four constituent hospitals (Ichilov General, Lis Maternity and Women's, Dana-Dwek Children's, and Ida Sourasky Rehabilitation) plus a dedicated emergency medicine hospital and an underground emergency facility. It delivers comprehensive inpatient, outpatient, emergency, maternity, pediatric, and rehabilitation services to approximately 1.5–2 million patients annually across 1,500+ beds and 250 specialist clinics. In parallel, it runs 2,700 active clinical trials and serves international patients through a dedicated medical tourism unit, a telemedicine service, and the Ichilov AID humanitarian program.

Product overview

Tel Aviv Sourasky Medical Center (Ichilov) operates as a multi-hospital academic medical center comprising four main hospitals: Ichilov General Hospital, Lis Maternity and Women's Hospital, Dana-Dwek Children's Hospital, and Ida Sourasky Rehabilitation Hospital, plus the Sylvan Adams Emergency Medicine Hospital and I-NEXT Research and Innovation center. The center provides digital services through its BeWell personal health portal, the GECKO clinical information platform, and the Seegnal Prescription Intelligence Platform. Additional offerings include telemedicine services, medical tourism services for international patients, and comprehensive specialty clinics and institutes. The hospital serves as a major tertiary care and referral center for the Tel Aviv metropolitan area and beyond.

Differentiator

Problem solved

Functional benefit

Products and services

• Ichilov General Hospital
• Lis Maternity and Women's Hospital
• Dana-Dwek Children's Hospital
• Ida Sourasky Rehabilitation Hospital
• Sylvan Adams Emergency Medicine Hospital
• BeShilam Rehabilitation Hospital for War Casualties
• Medical Tourism Services
• Telemedicine Services (Tele-Medical)
• BeWell Personal Health Portal
• AI Chatbot for Patient Service
• Ichilov AID Humanitarian Medical Program
• EMPC Emergency Preparedness Training Course

Quantifiable outcome

• Treated over 1.5 million patients annually with professional, high-quality care
• +4 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Partnerships

Eleven partnerships are on record, tiered core and minor.

• Seegnal Inc.coreTechnology or Integration · 1 January 2026Expanded deployment of Seegnal's Prescription Intelligence Platform at Tel Aviv Sourasky Medical Center from January 2026 through December 2027. The platform supports approximately 1,200 clinicians and 2,050 medical team members, providing real-time patient-specific medication decision support at point of care. The deployment serves as a case model for large-scale deployment in public healthcare systems worldwide.
• MatricelfcoreStrategic or Co-development Partner · 1 December 2025Partnership for manufacturing personalized regenerative spinal cord injury implants. Matricelf uses pioneering organ engineering technology developed at Tel Aviv University to create implants for paralysis treatment. Patient procedures expected to begin within approximately ten months.
• Xenetic Biosciences (via PeriNess)minorStrategic or Co-development PartnerXenetic's partner PeriNess received Israeli Ministry of Health approval for a clinical study combining DNase I with anti-CD19 CAR T cells in large B-cell lymphoma patients. The study is conducted at Tel Aviv Sourasky Medical Center based on positive preclinical results.
• Silexion TherapeuticscoreStrategic or Co-development PartnerSilexion received approval from the Helsinki Ethics Committee at Tel Aviv Sourasky Medical Center for a planned Phase 2/3 trial of SIL204 siRNA therapy targeting mutated KRAS in locally advanced pancreatic cancer.
• Tel Aviv University (Sackler Faculty of Medicine)coreStrategic or Co-development PartnerAffiliated teaching and research center with Sackler Faculty of Medicine at Tel Aviv University and Sheinborn School of Nursing. Thousands of staff provide world-class care while conducting research and training medical professionals.
• Israeli Ministry of Foreign Affairs (MASHAV)coreStrategic or Co-development PartnerIchilov AID humanitarian program works in partnership with Israeli Ministry of Foreign Affairs to deploy medical delegations to developing countries, providing expert patient care while building local healthcare capacity.
• Various international health organizations and hospitalsminorStrategic or Co-development PartnerIchilov AID has sent delegations to Myanmar, Liberia, India, Guatemala, Brazil, Nepal, Philippines, and more. Establishes temporary health camps, provides medical services, delivers training, and donates equipment while maintaining continuity through return visits.
• Israeli Ministry of Health and Home Front CommandcoreStrategic or Co-development PartnerUnderground hospital infrastructure developed in close coordination with Israel's Ministry of Health and Home Front Command. Integrated Hospital-to-Underground protocol enables full relocation of critical services within 7 hours.
• Yale School of MedicinecoreStrategic or Co-development PartnerInternational clinical trial partner for Phase I/II clinical trials including Clearmind Medicine's CMND-100 trial for Alcohol Use Disorder. Multinational, multicenter study conducted under FDA oversight.
• Johns Hopkins University School of MedicinecoreStrategic or Co-development PartnerInternational clinical trial partner for Phase I/II clinical trials. Multinational study site for Clearmind Medicine's CMND-100 trial and other clinical programs.
• Hadassah Medical CentercoreStrategic or Co-development PartnerIsraeli clinical trial partner for Phase I/II clinical trials including Clearmind Medicine's CMND-100 trial for Alcohol Use Disorder. Multicenter trial sites across Israel.

Scale indicators14 records

Recent moves12 records

Expansion highlights7 records

Direct peers

• Rambam Health Care Campus: Northern Israel's largest academic medical center and public hospital with similar multi-specialty depth, large-scale emergency/trauma operations, and government affiliation. Comparable on inpatient capacity, research activity, and northern-region referral dynamics.
• Hadassah Medical Center: Major Jerusalem-based academic medical center explicitly named as a TASMC trial partner for the Clearmind Medicine CMND-100 study. Operates with similar public/academic model, multi-hospital structure, and clinical research scale.
• Sheba Medical Center: Israel's largest hospital and #1-ranked academic medical center, also public and serving the Tel Aviv region with comparable research intensity and government affiliation. Direct competitor for talent, research funding, and international patient referrals.
• Assuta Medical Center: Israel's largest private hospital network, operating under a fundamentally different funding model but serving an overlapping patient base in the Tel Aviv metropolitan area. Key reference point for private-system pricing and medical tourism positioning within Israel.
• Anadolu Medical Center: Johns Hopkins-affiliated Turkish medical center heavily oriented to medical tourism and clinical trials. Comparable on JCI-accredited international patient services and active clinical research partnerships with U.S. academic centers.
• Bumrungrad International Hospital: Asia's leading medical tourism hospital, treating over a million international patients annually. Direct comparable on medical tourism positioning, JCI accreditation, and multilingual international patient services.

Broad incumbents

• Mayo Clinic: Global benchmark for academic medical centers and international patient destination. Comparable on integrated multi-specialty care, research intensity, and JCI-style quality positioning, though at substantially larger scale and price point.
• Cleveland Clinic: U.S.-based academic medical center with global expansion (including Cleveland Clinic Abu Dhabi). Comparable on multi-site specialty centers of excellence model, medical tourism orientation, and clinical research scale.
• Johns Hopkins Hospital: U.S. academic medical center explicitly named as a TASMC research partner for the Clearmind Medicine CMND-100 multinational Phase I/II trial. Comparable on top-tier research intensity and clinical trial scale.
• Charité – Universitätsmedizin Berlin: Europe's largest university hospital, affiliated with Humboldt and Free University of Berlin. Comparable on public-university academic medical center model, multi-hospital structure, and large-scale research operations.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/tasmc1
• YouTubeyoutube.com/user/tasmc1
• Facebookfacebook.com/182388545141732
• LinkedInlinkedin.com/company/tel-aviv-medical-center
• Instagraminstagram.com/ichilovtlv

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles20 records

Subsidiaries8 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tel Aviv Sourasky Medical Center